K, A., A, R., B, D., S, U. H., A, M., M, Z., . . . M, M. F. E. (2025). The synergistic potential of camrelizumab and rivoceranib in advanced hepatocellular carcinoma: A review of current evidence. Annals of medicine and surgery (2012), 87(9), 5598. https://doi.org/10.1097/MS9.0000000000003597
Chicago Style (17th ed.) CitationK, Ahmed, et al. "The Synergistic Potential of Camrelizumab and Rivoceranib in Advanced Hepatocellular Carcinoma: A Review of Current Evidence." Annals of Medicine and Surgery (2012) 87, no. 9 (2025): 5598. https://doi.org/10.1097/MS9.0000000000003597.
MLA (9th ed.) CitationK, Ahmed, et al. "The Synergistic Potential of Camrelizumab and Rivoceranib in Advanced Hepatocellular Carcinoma: A Review of Current Evidence." Annals of Medicine and Surgery (2012), vol. 87, no. 9, 2025, p. 5598, https://doi.org/10.1097/MS9.0000000000003597.